Sector: MedTech / AI in Diagnostics
Location: France (remote), with frequent travel across Europe and North America
Package: Competitive salary + equity
THE CLIENT:
Our client is a growth-stage MedTech company developing certified AI diagnostic solutions for pathology and oncology. Their solutions help clinical specialists deliver precision diagnostics across multiple cancer indications. The company is backed by institutional investors and distributed through established partners in the digital health ecosystem. They prioritise being trusted and clinically useful over making big claims.
THE ROLE:
We're seeking a Director of Medical Affairs who combines deep clinical expertise with strategic business acumen. You'll own the company's medical, clinical and market access strategy across Europe and North America. You'll build the clinical evidence base, KOL network, and reimbursement pathways that will scale diagnostic solutions. The position reports to the CEO.
Responsibilities:
• KOL and advisory board management – Identify, engage and manage a network of specialist KOLs across Europe and North America. Organise and lead Advisory Boards to shape clinical strategy. Represent the company at major scientific congresses (ESMO, ASCO, EADO and equivalents).
• Clinical development and data generation – Define and execute clinical data strategy across multiple indications and geographies. Design and write study protocols in line with ICH GCP standards. Initiate, monitor, and close clinical studies end-to-end. Engage hospital networks directly to unlock cohorts and data. Ensure regulatory and pharmacovigilance obligations are met.
• Partnerships – Build and manage strategic partnerships with pharmaceutical companies and academic institutions. Negotiate collaboration agreements. Drive scientific publications and congress abstracts with partners.
• Market access – Develop and execute market access strategy, including HEOR evidence generation and reimbursement dossiers. Engage scientific societies to support guideline inclusion. Interface with HTA bodies as needed.
What Success Looks Like:
• 12 months: KOL network mapped and activated across Europe and North America, first prospective study initiated, first pharma partnership signed.
• 18 months: Multiple ongoing studies with data readouts, market access milestones secured, established presence at key industry congresses.
Requirements:
• MD or PharmD with strong expertise in oncology clinical development
• 5-8 years of post-qualification experience in pharmaceutical or medtech clinical development or medical affairs
• Deep, first-hand knowledge of the hospital ecosystem: departmental operations, decision-making structures, and study initiation processes
• Solid understanding of oncology treatment paradigms and drug classes (immunotherapy, targeted therapies, chemotherapy)
• Hands-on experience designing and managing Phase II or III oncology clinical trials under ICH GCP
• Existing, credible network of oncology KOLs
• Track record in pharma/medtech partnerships and business development
• Working knowledge of market access processes in Europe and North America (HEOR, reimbursement, HTA pathways)
• Scientific publication record in peer-reviewed oncology journals
• Builder mindset: hands-on, resourceful, comfortable with ambiguity and fast-moving environments
• Fluent in French and English
• Willingness to travel extensively between Europe and North America
Nice to Have:
• Prior experience in oncology franchises within pharma
• Prior experience in digital health, AI diagnostics, or companion diagnostics companies
• Existing relationships with pharmaceutical medical affairs teams
• Experience with regulatory pathways (CE, FDA)
What's on Offer:
• Senior position on a small executive team with real decision-making autonomy
• Direct exposure to a growing international customer and partner base
• The opportunity to build something at scale rather than maintain existing structures
• Dynamic, collaborative environment with direct access to leadership